首頁 > 市場調查報告書 > 醫療設備

婦科治療

市場調查報告書

商品編碼

1668668

2025 年全球子宮肌瘤治療市場報告

Uterine Fibroids Treatment Global Market Report 2025

出版日期: 2025年02月28日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年子宮肌瘤治療市場規模將強勁成長。到 2029 年，這一數字將成長至 64.6 億美元，複合年成長率為 9.8%。預測期內的成長可歸因於非侵入性治療的進步、對生育能力保存的日益重視、微創技術的興起、個人化醫療方法以及合作研究和開發。預測期內的關鍵趨勢包括更加關注生育能力保留治療、將影像技術整合到治療計劃中、提高意識和教育舉措、根據患者情況量身定做治療計劃以及探索新的治療目標。

子宮肌瘤治療市場的預期成長是由於女性子宮肌瘤的盛行率很高。子宮肌瘤是子宮內的非癌性腫瘤，可引起月經量過多、骨盆腔疼痛、膀胱或腸道受壓等症狀。子宮肌瘤的治療包括阻止雌激素和黃體素的產生、停止月經和改善貧血。例如，根據美國國家生物技術資訊中心2022年11月發布的報告，估計子宮肌瘤在35歲以下女性的發生率為40-60%，在50歲以上女性的發生率為70-80%。因此，全球子宮肌瘤的流行正在推動子宮肌瘤治療市場的成長。

醫療保健支出的預期成長將推動子宮肌瘤治療市場的發展。醫療支出是指一個國家、政府、組織或個人在時限用於醫療衛生相關商品和服務的總財政資源。醫療保健支出的增加正在支持先進子宮肌瘤治療方案的開發和採用，包括子宮動脈栓塞和磁振導航聚焦超音波手術等微創手術。例如，波蘭2022年的醫療保健支出將達到2,056億茲羅提（509.9億美元），佔GDP的6.7%，比2021年增加約361億茲羅提（89.5億美元）。因此，醫療支出的增加正在促進子宮肌瘤治療市場的擴大。

全球子宮肌瘤治療PESTEL分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
最終用途產業分析
全球子宮肌瘤治療市場：成長率分析
全球子宮肌瘤治療市場表現：規模與成長，2019 年至 2024 年
全球子宮肌瘤治療市場預測：2024-2029 年及 2034 年規模與成長
全球子宮肌瘤治療總潛在市場 (TAM)

第6章市場細分

全球子宮肌瘤治療市場類型、表現及預測，2019-2024 年、2024-2029 年、2034 年
漿膜下肌瘤
子宮壁內肌瘤
黏膜下肌瘤
帶蒂子宮肌瘤
全球子宮肌瘤治療市場依治療類型、表現及預測，2019-2024 年、2024-2029 年、2034 年
荷爾蒙療法
雄激素
促性腺激素分泌釋放激素拮抗劑
子宮動脈栓塞術
子宮肌瘤切除術
子宮切除術
全球子宮肌瘤治療市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
醫院
門診手術中心
其他最終用戶
全球子宮肌瘤治療市場細分（按類型、績效和預測），2019-2024 年、2024-2029 年、2034 年
帶蒂漿膜下肌瘤
無蒂漿膜下肌瘤
全球子宮肌瘤治療市場，壁內肌瘤細分，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
小壁間肌瘤
大型壁間肌瘤
全球子宮肌瘤治療市場細分（按黏膜下纖維瘤類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
帶蒂粘膜下纖維瘤
無蒂黏膜下纖維瘤
全球子宮肌瘤治療市場帶蒂子宮肌瘤細分，按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
漿膜下帶蒂肌瘤
黏膜下帶蒂肌瘤

第7章區域和國家分析

全球子宮肌瘤治療市場：按地區、表現和預測，2019-2024 年、2024-2029 年、2034 年
全球子宮肌瘤治療市場：按國家分類、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第 17 章德國市場

第 18 章法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第 25 章：加拿大市場

第26章南美洲市場

第 27 章：巴西市場

第28章中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

子宮肌瘤治療市場：競爭格局
子宮肌瘤治療市場：公司簡介
- Gynesonics Inc. Overview, Products and Services, Strategy and Financial Analysis
- Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- Karl Storz GmbH Overview, Products and Services, Strategy and Financial Analysis
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

Abbvie Inc.
Richard Wolf GmbH
CooperSurgical Inc.
Olympus Corporation
Myovant Sciences GmbH
Insightec Ltd.
Hologic Inc.
Obseva SA
Eli Lilly and Company
GlaxoSmithKline plc
Stryker Corporation
Smith & Nephew plc
Minerva Surgical Inc.
Ethicon Inc.
Cook Medical LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第 34 章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

2029 年子宮肌瘤治療市場：提供新機會的國家
子宮肌瘤治療市場 2029：細分市場提供新機會
子宮肌瘤治療市場 2029：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第 36 章附錄

簡介目錄

Product Code: r24576

Uterine fibroids treatment encompasses procedures aimed at addressing uterine fibroids, which are non-cancerous growths that form in the uterus, potentially leading to symptoms such as heavy menstrual bleeding, pelvic pain, and pressure on the bladder or bowel.

The primary categories of uterine fibroids treatment consist of subserosal fibroids, intramural fibroids, submucosal fibroids, and pedunculated fibroids. Subserosal fibroids, also known as pedunculated fibroids, are benign growths located on the outer uterine wall, directly connected to the uterus. Various treatment options are available, including hormone therapy, androgens, gonadotropin-releasing hormone antagonists, uterine artery embolization, myomectomy, and hysterectomy. These treatments cater to diverse end-users such as hospitals, ambulatory surgical centers, and others.

The uterine fibroid treatment market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid treatment market statistics, including uterine fibroid treatment industry global market size, regional shares, competitors with a uterine fibroid treatment market share, detailed uterine fibroid treatment market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid treatment industry. This uterine fibroid treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroids treatment market size has grown strongly in recent years. It will grow from$4.06 billion in 2024 to $4.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increased incidence of uterine fibroids, advancements in diagnostic techniques, rising awareness and education, impact on quality of life, evolution of minimally invasive procedures

The uterine fibroids treatment market size is expected to see strong growth in the next few years. It will grow to $6.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to advancements in non-invasive treatment, increasing emphasis on fertility preservation, rise in minimally invasive techniques, personalized medicine approaches, collaborative research and development. Major trends in the forecast period include rising focus on fertility-preserving treatments, integration of imaging technologies in treatment planning, increasing awareness and education initiatives, customized treatment plans based on patient profiles, exploration of novel therapeutic targets.

The anticipated growth in the uterine fibroids treatment market is attributed to the high prevalence of uterine fibroids among women. Uterine fibroids, non-cancerous growths in the uterus, can lead to symptoms such as heavy menstrual bleeding, pelvic pain, and pressure on the bladder or bowel. Uterine fibroids treatment involves blocking estrogen and progesterone production, ceasing menstruation, and improving anemia. For example, a November 2022 report from the National Centre for Biotechnology Information revealed an estimated incidence of uterine fibroids ranging from 40 to 60% among women under 35 and 70 to 80% among women over 50. Thus, the widespread prevalence of uterine fibroids worldwide propels the uterine fibroids treatment market's growth.

The expected rise in healthcare expenditure is set to drive the uterine fibroids treatment market. Healthcare expenditure denotes the total financial resources allocated by a country, government, organization, or individual for healthcare-related goods and services within a specific timeframe. Increased healthcare expenditure supports the development and adoption of advanced uterine fibroids treatment options, including minimally invasive procedures such as uterine artery embolization or magnetic resonance-guided focused ultrasound surgery. For instance, in 2022, Poland's healthcare expenditure reached PLN 205.6 billion ($50.99 billion), representing 6.7% of GDP, a growth of about PLN 36.1 billion ($8.95 billion) from 2021. Hence, the escalating healthcare expenditure contributes to the uterine fibroids treatment market's expansion.

Product innovations are emerging as a significant trend in the uterine fibroid treatment market. Companies in this sector are implementing innovative solutions to maintain their competitive edge. For example, in September 2024, Kissei Pharmaceutical Co., Ltd., a pharmaceutical company based in Japan, launched YSELTY, a new treatment for uterine fibroids that represents a major advancement in women's healthcare. YSELTY provides a non-hormonal treatment option with flexible dosing tailored to individual patient needs, especially for those experiencing severe fibroid symptoms. As a GnRH receptor antagonist, YSELTY works by inhibiting gonadotropin-releasing hormone at its pituitary receptors, thereby reducing estrogen production and effectively alleviating symptoms like bleeding and pain.

Significant players in the uterine fibroids treatment market are directing their efforts toward developing minimally invasive procedures (MIPs) for addressing uterine fibroids. Minimally invasive procedures involve medical interventions or surgeries that cause minimal disruption to the body's normal structure and function. These procedures aim to alleviate symptoms such as heavy menstrual bleeding and pelvic pain while reducing recovery times and preserving reproductive options. As an illustration, Humber River Hospital in Canada launched the use of the Acessa ProVu system in November 2022. This medical technology employs monopolar radiofrequency (RF) energy through a disposable Handpiece for percutaneous, laparoscopic coagulation, and ablation of soft tissue, including the treatment of symptomatic uterine fibroids.

In January 2022, Hologic Inc., a US-based medical technology company, acquired Acessa Health for $80 million, enhancing Hologic's presence in the gynecological surgical space. Acessa Health, a US-based biotechnology company, specializes in developing minimally invasive, uterine-sparing devices designed to treat women suffering from symptomatic fibroids.

Major companies operating in the uterine fibroids treatment market include Gynesonics Inc., Medtronic plc, Boston Scientific Corporation, Karl Storz GmbH, Pfizer Inc., Abbvie Inc., Richard Wolf GmbH, CooperSurgical Inc., Olympus Corporation, Myovant Sciences GmbH, Insightec Ltd., Hologic Inc., Obseva SA, Eli Lilly and Company, GlaxoSmithKline plc, Stryker Corporation, Smith & Nephew plc, Minerva Surgical Inc., Ethicon Inc., Cook Medical LLC, C.R. Bard Inc., Biomerics LLC, Visionsense Corp., Halt Medical Inc., Acessa Health Inc., Blue Endo, LiNA Medical ApS, Merit Medical Systems Inc., Allergan plc, Astellas Pharma Inc.

North America was the largest region in the uterine fibroids treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the uterine fibroids treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the uterine fibroids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The uterine fibroids treatment market includes revenues earned by entities by providing medical, surgical, and radiologically guided therapies available as treatments for uterine fibroids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroids Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uterine fibroids treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroids treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uterine fibroids treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Subserosal Fibroids; Intramural Fibroids; Submucosal Fibroids; Pedunculated Fibroids
2) By Treatment Type: Hormone Therapy; Androgens; Gonadotropin-Releasing Hormone Antagonists; Uterine Artery Embolization; Myomectomy; Hysterectomy
3) By End-Users: Hospitals; Ambulatory Surgical Centers; Other End users
Subsegments:
1) By Subserosal Fibroids: Pedunculated Subserosal Fibroids; Non-Pedunculated Subserosal Fibroids
2) By Intramural Fibroids: Small Intramural Fibroids; Large Intramural Fibroids
3) By Submucosal Fibroids: Pedunculated Submucosal Fibroids; Non-Pedunculated Submucosal Fibroids
4) By Pedunculated Fibroids: Subserosal Pedunculated Fibroids; Submucosal Pedunculated Fibroids
Companies Mentioned: Gynesonics Inc.; Medtronic plc; Boston Scientific Corporation; Karl Storz GmbH; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Uterine Fibroids Treatment Market Characteristics

3. Uterine Fibroids Treatment Market Trends And Strategies

4. Uterine Fibroids Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Uterine Fibroids Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Uterine Fibroids Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Uterine Fibroids Treatment Market Growth Rate Analysis
5.4. Global Uterine Fibroids Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Uterine Fibroids Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Uterine Fibroids Treatment Total Addressable Market (TAM)

6. Uterine Fibroids Treatment Market Segmentation

6.1. Global Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Pedunculated Fibroids
6.2. Global Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormone Therapy
Androgens
Gonadotropin-Releasing Hormone Antagonists
Uterine Artery Embolization
Myomectomy
Hysterectomy
6.3. Global Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Other End users
6.4. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Subserosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pedunculated Subserosal Fibroids
Non-Pedunculated Subserosal Fibroids
6.5. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Intramural Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Intramural Fibroids
Large Intramural Fibroids
6.6. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Submucosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pedunculated Submucosal Fibroids
Non-Pedunculated Submucosal Fibroids
6.7. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Pedunculated Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subserosal Pedunculated Fibroids
Submucosal Pedunculated Fibroids

7. Uterine Fibroids Treatment Market Regional And Country Analysis

7.1. Global Uterine Fibroids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Uterine Fibroids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uterine Fibroids Treatment Market

8.1. Asia-Pacific Uterine Fibroids Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uterine Fibroids Treatment Market

9.1. China Uterine Fibroids Treatment Market Overview
9.2. China Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uterine Fibroids Treatment Market

10.1. India Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uterine Fibroids Treatment Market

11.1. Japan Uterine Fibroids Treatment Market Overview
11.2. Japan Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uterine Fibroids Treatment Market

12.1. Australia Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uterine Fibroids Treatment Market

13.1. Indonesia Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uterine Fibroids Treatment Market

14.1. South Korea Uterine Fibroids Treatment Market Overview
14.2. South Korea Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uterine Fibroids Treatment Market

15.1. Western Europe Uterine Fibroids Treatment Market Overview
15.2. Western Europe Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uterine Fibroids Treatment Market

16.1. UK Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uterine Fibroids Treatment Market

17.1. Germany Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uterine Fibroids Treatment Market

18.1. France Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uterine Fibroids Treatment Market

19.1. Italy Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uterine Fibroids Treatment Market

20.1. Spain Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uterine Fibroids Treatment Market

21.1. Eastern Europe Uterine Fibroids Treatment Market Overview
21.2. Eastern Europe Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uterine Fibroids Treatment Market

22.1. Russia Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uterine Fibroids Treatment Market

23.1. North America Uterine Fibroids Treatment Market Overview
23.2. North America Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uterine Fibroids Treatment Market

24.1. USA Uterine Fibroids Treatment Market Overview
24.2. USA Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uterine Fibroids Treatment Market

25.1. Canada Uterine Fibroids Treatment Market Overview
25.2. Canada Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uterine Fibroids Treatment Market

26.1. South America Uterine Fibroids Treatment Market Overview
26.2. South America Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uterine Fibroids Treatment Market

27.1. Brazil Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uterine Fibroids Treatment Market

28.1. Middle East Uterine Fibroids Treatment Market Overview
28.2. Middle East Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uterine Fibroids Treatment Market

29.1. Africa Uterine Fibroids Treatment Market Overview
29.2. Africa Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uterine Fibroids Treatment Market Competitive Landscape And Company Profiles

30.1. Uterine Fibroids Treatment Market Competitive Landscape
30.2. Uterine Fibroids Treatment Market Company Profiles
- 30.2.1. Gynesonics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Karl Storz GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Uterine Fibroids Treatment Market Other Major And Innovative Companies

31.1. Abbvie Inc.
31.2. Richard Wolf GmbH
31.3. CooperSurgical Inc.
31.4. Olympus Corporation
31.5. Myovant Sciences GmbH
31.6. Insightec Ltd.
31.7. Hologic Inc.
31.8. Obseva SA
31.9. Eli Lilly and Company
31.10. GlaxoSmithKline plc
31.11. Stryker Corporation
31.12. Smith & Nephew plc
31.13. Minerva Surgical Inc.
31.14. Ethicon Inc.
31.15. Cook Medical LLC

32. Global Uterine Fibroids Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uterine Fibroids Treatment Market

34. Recent Developments In The Uterine Fibroids Treatment Market

35. Uterine Fibroids Treatment Market High Potential Countries, Segments and Strategies

35.1 Uterine Fibroids Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Uterine Fibroids Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Uterine Fibroids Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies